XKRX
357780
Market cap1.50bUSD
Jul 10, Last price
311,500.00KRW
1D
5.59%
1Q
-27.47%
IPO
10.46%
Name
SoulBrain Co Ltd
Chart & Performance
P/E
30.18
P/S
2.58
EPS
10,322.68
Div Yield, %
0.78%
Shrs. gr., 5y
0.03%
Rev. gr., 5y
14.46%
Revenues
923.38b
+6.95%
Net income
79.06b
-33.25%
CFO
146.92b
-44.00%
Dividend
Mar 28, 20252300 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Seongnam-si, South Korea, Soulbrain Co., Ltd. specializes in the development, production, and distribution of essential advanced materials for various high-technology sectors. Their extensive product portfolio includes critical components for semiconductor manufacturing, such as CVD/ALD substances, specialized etching and cleaning agents (including hydrofluoric acid and buffered oxide etchants for silicon oxide films), chemical mechanical planarization (CMP) slurries, and plating solutions. The company is also a key supplier of functional chemical materials for liquid crystal display (LCD) and organic light-emitting diode (OLED) panels, encompassing elements for thin glass and cell scribing processes. Furthermore, Soulbrain contributes to green energy technologies with electronic materials for LED processing, solar cells, and electric vehicle applications. Diversifying its operations, Soulbrain also manufactures cosmetic products, notably hydrogel mask packs. It has a footprint in healthcare technology, offering electronic health record (EHR) and personal health record (PHR) platforms, alongside body concentration and drug-testing solutions. Additionally, the company provides a range of financial services, including funding for new technologies, M&A advisory, and operating a lending institution.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||